Top Headlines
Pharmaceutical Business Review
Novo Nordisk reports positive results from Phase-3 haemophilia B study of N9-GP
Novo Nordisk has reported positive results from Phase-3 study of FIX derivative N9-GP to treat haemophilia B.
Contract Research & Services > Clinical Trials > News
Impax introduces authorized generic of Zomig in US
By
Impax Laboratories has introduced authorized generic of Zomig (zolmitriptan) tablets and orally disintegrating tablets, 2.5mg and 5mg, in the US.
Drug Research > Drug Discovery & Development > News Cellular enrolls 50% patients in Phase I knee osteoarthritis trial By
Cellular Biomedicine has achieved 50% enrollment milestone in Phase I open label clinical research trial for knee osteoarthritis (KOA).
Contract Research & Services > Clinical Trials > News ImmunoCellular obtains US patent covering use of interleukin 13-receptor alpha 2 protein By
ImmunoCellular Therapeutics has obtained US patent for methods of use of interleukin 13-receptor alpha 2 protein (IL-13Rα2) in cancer immunotherapy.
Regulatory Affairs > News
Impax Laboratories has introduced authorized generic of Zomig (zolmitriptan) tablets and orally disintegrating tablets, 2.5mg and 5mg, in the US.
Drug Research > Drug Discovery & Development > News Cellular enrolls 50% patients in Phase I knee osteoarthritis trial By
Cellular Biomedicine has achieved 50% enrollment milestone in Phase I open label clinical research trial for knee osteoarthritis (KOA).
Contract Research & Services > Clinical Trials > News ImmunoCellular obtains US patent covering use of interleukin 13-receptor alpha 2 protein By
ImmunoCellular Therapeutics has obtained US patent for methods of use of interleukin 13-receptor alpha 2 protein (IL-13Rα2) in cancer immunotherapy.
Regulatory Affairs > News
DBV, Stallergenes sign strategic research partnership targeting respiratory allergies
By
DBV Technologies and Stallergenes have signed a strategic research partnership for the development of new treatment of respiratory allergies.
Contract Research & Services > Contract Research > News RuiYi, Genor sign RYI-008 development deal in China By
RuiYi and Genor BioPharma have signed an exclusive license and collaborative development agreement for RYI-008 in China.
News Novo Nordisk reports positive results from Phase-3 haemophilia B study of N9-GP By
Novo Nordisk has reported positive results from Phase-3 study of FIX derivative N9-GP to treat haemophilia B.
Contract Research & Services > Clinical Trials > News
DBV Technologies and Stallergenes have signed a strategic research partnership for the development of new treatment of respiratory allergies.
Contract Research & Services > Contract Research > News RuiYi, Genor sign RYI-008 development deal in China By
RuiYi and Genor BioPharma have signed an exclusive license and collaborative development agreement for RYI-008 in China.
News Novo Nordisk reports positive results from Phase-3 haemophilia B study of N9-GP By
Novo Nordisk has reported positive results from Phase-3 study of FIX derivative N9-GP to treat haemophilia B.
Contract Research & Services > Clinical Trials > News
Latest News and Insight by Sector
Production & Manufacturing
Nordion, Navidea sign contract manufacturing agreement
Nordion has entered into a contract manufacturing agreement with Navidea Biopharmaceuticals for NAV5001 a diagnostic imaging agent used to detect Parkinsonian Syndromes and Dementia with Lewy Bodies.
Production & Manufacturing > Manufacturing > News
Production & Manufacturing > Manufacturing > News
Bend Research expands manufacturing capabilities to support pharmaceutical development
Bend Research has announced the expansion of its good manufacturing practice (GMP) analytical capabilities and capacity to support pharmaceutical development.
Production & Manufacturing > Manufacturing > News
Production & Manufacturing > Manufacturing > News
Drug Research
Impax introduces authorized generic of Zomig in US
Impax Laboratories has introduced authorized generic of Zomig (zolmitriptan) tablets and orally disintegrating tablets, 2.5mg and 5mg, in the US.
Drug Research > Drug Discovery & Development > News
Drug Research > Drug Discovery & Development > News
Almac secures BBSRC programme with UCL
UK-based Almac biocatalysis has secured a Biotechnology and Biological Sciences Research Council (BBSRC) programme with University College London (UCL) aimed at metagenomics and novel enzyme discovery.
Drug Research > Drug Discovery & Development > News
Drug Research > Drug Discovery & Development > News
Inward Investment
Bayer to acquire Steigerwald Arzneimittelwerk
Bayer has signed an agreement to purchase 100% of the shares of Steigerwald Arzneimittelwerk.
Inward Investment > News
Inward Investment > News
Sagent Pharmaceuticals to acquire remaining stake in KSPC JV
Sagent Pharmaceuticals has signed an agreement to acquire 50% interest of its joint venture (JV) partner, Chengdu Kanghong Pharmaceuticals, in the Kanghong Sagent Pharmaceutical (KSPC) JV, for $25m.
Inward Investment > News
Inward Investment > News
Packaging
Contract Research & Services
Cellular enrolls 50% patients in Phase I knee osteoarthritis trial
Cellular Biomedicine has achieved 50% enrollment milestone in Phase I open label clinical research trial for knee osteoarthritis (KOA).
Contract Research & Services > Clinical Trials > News
Contract Research & Services > Clinical Trials > News
DBV, Stallergenes sign strategic research partnership targeting respiratory allergies
DBV Technologies and Stallergenes have signed a strategic research partnership for the development of new treatment of respiratory allergies.
Contract Research & Services > Contract Research > News
Contract Research & Services > Contract Research > News
Automation
UCB, IBM collaborate on super-computer project to improve epilepsy care
UCB and IBM have announced the completion of the initial phase of project designed to exploit super-computer power for better care for epilepsy patients.
Automation > IT & Software > News
Automation > IT & Software > News
PerkinElmer expands OneSource laboratory consulting services
PerkinElmer has expanded its OneSource laboratory services to include strategic laboratory consulting services.
Automation > IT & Software > News
Automation > IT & Software > News
Regulatory Affairs
ImmunoCellular obtains US patent covering use of interleukin 13-receptor alpha 2 protein
ImmunoCellular Therapeutics has obtained US patent for methods of use of interleukin 13-receptor alpha 2 protein (IL-13Rα2) in cancer immunotherapy.
Regulatory Affairs > News
Regulatory Affairs > News
Alethia gains US patent for cancer treatment methods
Alethia Biotherapeutics has gained US patent for methods of treating carcinomas with antibodies targeting the region of secreted clusterin (sCLU) responsible for promoting epithelial-to-mesenchymal transition (EMT).
Regulatory Affairs > News
Regulatory Affairs > News
Buy the latest industry research online today!
African Pharmaceutical Directory 2013
API research into pharmaceutical companies and corporations
Reports
Buy online from $200
Training Course on Medical Approach in Diagnosis and Management of ADRs
19 September 2011
Events
Training Course on Advanced GCP Study Monitoring
19 September 2011
Events
IDMP Information Day (2nd)
23 September 2011
Events